An Act amending the act of April 17, 2016 (P.L.84, No.16), known as the Medical Marijuana Act, in preliminary provisions, further providing for definitions; in practitioners, further providing for practitioner registration; in medical marijuana controls, further providing for electronic tracking and for laboratory; and, in Medical Marijuana Advisory Board, further providing for advisory board.

HB 33 amends Pennsylvania's Medical Marijuana Act to clarify definitions and strengthen oversight of testing labs and practitioners. It defines key terms like "independent laboratory" (requiring no ties to marijuana businesses) and "approved laboratory" (testing medical marijuana samples under department approval). The bill gives the Department of Health new authority to impose conditions on medical practitioners, such as limiting certifications or requiring supervision, to protect patient safety. These changes directly affect medical marijuana patients, healthcare providers who certify them, and labs testing products for quality and safety. The updates aim to improve accountability in the program through clearer rules for lab accreditation and practitioner oversight.